Edney, Laura C. http://orcid.org/0000-0002-2447-4118
Lomas, James http://orcid.org/0000-0003-2329-7831
Karnon, Jonathan http://orcid.org/0000-0003-3220-2099
Vallejo-Torres, Laura
Stadhouders, Niek http://orcid.org/0000-0002-7296-2335
Siverskog, Jonathan http://orcid.org/0000-0003-4853-5576
Paulden, Mike http://orcid.org/0000-0002-0381-5980
Edoka, Ijeoma P. http://orcid.org/0000-0003-4268-3092
Ochalek, Jessica http://orcid.org/0000-0003-0744-1178
Article History
Accepted: 2 September 2021
First Online: 29 September 2021
Declarations
:
: This work draws on research supported by the Patented Medicines Price Review Board (PMPRB). The views expressed herein do not necessarily represent the official policy of the PMPRB. The agreement with the PMPRB ensured the authors’ independence in designing, writing and publishing the report. Laura Vallejo-Torres would additionally like to acknowledge the support of the project RTI2018-096365-J-I00.
: Laura C. Edney, James Lomas, Jonathan Karnon, Laura Vallejo-Torres, Niek Stadhouders, Jonathan Siverskog, Mike Paulden, Ijeoma P. Edoka, and Jessica Ochalek have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: LCE, JO, JL and JK conceived the study design. LCE, JO and JL drafted the initial manuscript. All authors commented on previous versions of the manuscript and approved the final manuscript.
Free to read: This content has been made available to all.